Connection
Justin Honce to Fingolimod Hydrochloride
This is a "connection" page, showing publications Justin Honce has written about Fingolimod Hydrochloride.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.150 |
|
|
|
-
Vollmer B, Honce JM, Sillau S, Corboy JR, Vollmer T, Nair K, Alvarez E. The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis. J Neurol Sci. 2018 07 15; 390:89-93.
Score: 0.150